> top > docs > PubMed:15868402 > annotations

PubMed:15868402 JSONTXT

Annnotations TAB JSON ListView MergeView

DisGeNET5_variant_disease

Id Subject Object Predicate Lexical cue
15868402-4#218#223#geners1136410 672-677 geners1136410 denotes V762A
15868402-4#138#154#diseaseC0205851 592-608 diseaseC0205851 denotes germ cell tumors
15868402-4#237#252#diseaseC0376358 691-706 diseaseC0376358 denotes prostate cancer
15868402-4#237#252#diseaseC0600139 691-706 diseaseC0600139 denotes prostate cancer
218#223#geners1136410138#154#diseaseC0205851 15868402-4#218#223#geners1136410 15868402-4#138#154#diseaseC0205851 associated_with V762A,germ cell tumors
218#223#geners1136410237#252#diseaseC0376358 15868402-4#218#223#geners1136410 15868402-4#237#252#diseaseC0376358 associated_with V762A,prostate cancer
218#223#geners1136410237#252#diseaseC0600139 15868402-4#218#223#geners1136410 15868402-4#237#252#diseaseC0600139 associated_with V762A,prostate cancer

DisGeNET5_gene_disease

Id Subject Object Predicate Lexical cue
15868402-0#5#8#gene23038 760-763 gene23038 denotes ADP
15868402-0#49#67#diseaseC0004364 1276-1294 diseaseC0004364 denotes autoimmune disease
15868402-4#24#30#gene142 478-484 gene142 denotes PARP-1
15868402-4#24#30#gene25976 478-484 gene25976 denotes PARP-1
15868402-4#24#30#gene142 478-484 gene142 denotes PARP-1
15868402-4#24#30#gene25976 478-484 gene25976 denotes PARP-1
15868402-4#138#154#diseaseC0205851 592-608 diseaseC0205851 denotes germ cell tumors
15868402-4#237#252#diseaseC0376358 691-706 diseaseC0376358 denotes prostate cancer
15868402-4#237#252#diseaseC0600139 691-706 diseaseC0600139 denotes prostate cancer
15868402-4#237#252#diseaseC0376358 691-706 diseaseC0376358 denotes prostate cancer
15868402-4#237#252#diseaseC0600139 691-706 diseaseC0600139 denotes prostate cancer
15868402-5#47#78#gene8505 755-786 gene8505 denotes poly(ADP-ribose) glycohydrolase
15868402-5#47#78#gene670 755-786 gene670 denotes poly(ADP-ribose) glycohydrolase
15868402-5#80#84#gene8505 788-792 gene8505 denotes PARG
15868402-5#144#147#gene23038 852-855 gene23038 denotes ADP
15868402-5#161#165#gene8505 869-873 gene8505 denotes PARG
15868402-5#238#241#gene23038 946-949 gene23038 denotes ADP
15868402-5#255#269#diseaseC0596263 963-977 diseaseC0596263 denotes carcinogenesis
15868402-5#255#269#diseaseC0596263 963-977 diseaseC0596263 denotes carcinogenesis
15868402-6#116#122#gene142 1095-1101 gene142 denotes PARP-1
15868402-6#116#122#gene25976 1095-1101 gene25976 denotes PARP-1
15868402-6#148#168#diseaseC0003873 1127-1147 diseaseC0003873 denotes rheumatoid arthritis
15868402-7#20#26#gene142 1169-1175 gene142 denotes PARP-1
15868402-7#20#26#gene25976 1169-1175 gene25976 denotes PARP-1
15868402-7#28#32#gene8505 1177-1181 gene8505 denotes PARG
15868402-7#127#146#diseaseC0004364 1276-1295 diseaseC0004364 denotes autoimmune diseases
15868402-7#127#146#diseaseC0004364 1276-1295 diseaseC0004364 denotes autoimmune diseases
5#8#gene2303849#67#diseaseC0004364 15868402-0#5#8#gene23038 15868402-0#49#67#diseaseC0004364 associated_with ADP,autoimmune disease
24#30#gene142138#154#diseaseC0205851 15868402-4#24#30#gene142 15868402-4#138#154#diseaseC0205851 associated_with PARP-1,germ cell tumors
24#30#gene142237#252#diseaseC0376358 15868402-4#24#30#gene142 15868402-4#237#252#diseaseC0376358 associated_with PARP-1,prostate cancer
24#30#gene142237#252#diseaseC0600139 15868402-4#24#30#gene142 15868402-4#237#252#diseaseC0600139 associated_with PARP-1,prostate cancer
24#30#gene142237#252#diseaseC0376358 15868402-4#24#30#gene142 15868402-4#237#252#diseaseC0376358 associated_with PARP-1,prostate cancer
24#30#gene142237#252#diseaseC0600139 15868402-4#24#30#gene142 15868402-4#237#252#diseaseC0600139 associated_with PARP-1,prostate cancer
24#30#gene25976138#154#diseaseC0205851 15868402-4#24#30#gene25976 15868402-4#138#154#diseaseC0205851 associated_with PARP-1,germ cell tumors
24#30#gene25976237#252#diseaseC0376358 15868402-4#24#30#gene25976 15868402-4#237#252#diseaseC0376358 associated_with PARP-1,prostate cancer
24#30#gene25976237#252#diseaseC0600139 15868402-4#24#30#gene25976 15868402-4#237#252#diseaseC0600139 associated_with PARP-1,prostate cancer
24#30#gene25976237#252#diseaseC0376358 15868402-4#24#30#gene25976 15868402-4#237#252#diseaseC0376358 associated_with PARP-1,prostate cancer
24#30#gene25976237#252#diseaseC0600139 15868402-4#24#30#gene25976 15868402-4#237#252#diseaseC0600139 associated_with PARP-1,prostate cancer
24#30#gene142138#154#diseaseC0205851 15868402-4#24#30#gene142 15868402-4#138#154#diseaseC0205851 associated_with PARP-1,germ cell tumors
24#30#gene142237#252#diseaseC0376358 15868402-4#24#30#gene142 15868402-4#237#252#diseaseC0376358 associated_with PARP-1,prostate cancer
24#30#gene142237#252#diseaseC0600139 15868402-4#24#30#gene142 15868402-4#237#252#diseaseC0600139 associated_with PARP-1,prostate cancer
24#30#gene142237#252#diseaseC0376358 15868402-4#24#30#gene142 15868402-4#237#252#diseaseC0376358 associated_with PARP-1,prostate cancer
24#30#gene142237#252#diseaseC0600139 15868402-4#24#30#gene142 15868402-4#237#252#diseaseC0600139 associated_with PARP-1,prostate cancer
24#30#gene25976138#154#diseaseC0205851 15868402-4#24#30#gene25976 15868402-4#138#154#diseaseC0205851 associated_with PARP-1,germ cell tumors
24#30#gene25976237#252#diseaseC0376358 15868402-4#24#30#gene25976 15868402-4#237#252#diseaseC0376358 associated_with PARP-1,prostate cancer
24#30#gene25976237#252#diseaseC0600139 15868402-4#24#30#gene25976 15868402-4#237#252#diseaseC0600139 associated_with PARP-1,prostate cancer
24#30#gene25976237#252#diseaseC0376358 15868402-4#24#30#gene25976 15868402-4#237#252#diseaseC0376358 associated_with PARP-1,prostate cancer
24#30#gene25976237#252#diseaseC0600139 15868402-4#24#30#gene25976 15868402-4#237#252#diseaseC0600139 associated_with PARP-1,prostate cancer
47#78#gene8505255#269#diseaseC0596263 15868402-5#47#78#gene8505 15868402-5#255#269#diseaseC0596263 associated_with poly(ADP-ribose) glycohydrolase,carcinogenesis
47#78#gene8505255#269#diseaseC0596263 15868402-5#47#78#gene8505 15868402-5#255#269#diseaseC0596263 associated_with poly(ADP-ribose) glycohydrolase,carcinogenesis
47#78#gene670255#269#diseaseC0596263 15868402-5#47#78#gene670 15868402-5#255#269#diseaseC0596263 associated_with poly(ADP-ribose) glycohydrolase,carcinogenesis
47#78#gene670255#269#diseaseC0596263 15868402-5#47#78#gene670 15868402-5#255#269#diseaseC0596263 associated_with poly(ADP-ribose) glycohydrolase,carcinogenesis
80#84#gene8505255#269#diseaseC0596263 15868402-5#80#84#gene8505 15868402-5#255#269#diseaseC0596263 associated_with PARG,carcinogenesis
80#84#gene8505255#269#diseaseC0596263 15868402-5#80#84#gene8505 15868402-5#255#269#diseaseC0596263 associated_with PARG,carcinogenesis
144#147#gene23038255#269#diseaseC0596263 15868402-5#144#147#gene23038 15868402-5#255#269#diseaseC0596263 associated_with ADP,carcinogenesis
144#147#gene23038255#269#diseaseC0596263 15868402-5#144#147#gene23038 15868402-5#255#269#diseaseC0596263 associated_with ADP,carcinogenesis
161#165#gene8505255#269#diseaseC0596263 15868402-5#161#165#gene8505 15868402-5#255#269#diseaseC0596263 associated_with PARG,carcinogenesis
161#165#gene8505255#269#diseaseC0596263 15868402-5#161#165#gene8505 15868402-5#255#269#diseaseC0596263 associated_with PARG,carcinogenesis
238#241#gene23038255#269#diseaseC0596263 15868402-5#238#241#gene23038 15868402-5#255#269#diseaseC0596263 associated_with ADP,carcinogenesis
238#241#gene23038255#269#diseaseC0596263 15868402-5#238#241#gene23038 15868402-5#255#269#diseaseC0596263 associated_with ADP,carcinogenesis
116#122#gene142148#168#diseaseC0003873 15868402-6#116#122#gene142 15868402-6#148#168#diseaseC0003873 associated_with PARP-1,rheumatoid arthritis
116#122#gene25976148#168#diseaseC0003873 15868402-6#116#122#gene25976 15868402-6#148#168#diseaseC0003873 associated_with PARP-1,rheumatoid arthritis
20#26#gene142127#146#diseaseC0004364 15868402-7#20#26#gene142 15868402-7#127#146#diseaseC0004364 associated_with PARP-1,autoimmune diseases
20#26#gene142127#146#diseaseC0004364 15868402-7#20#26#gene142 15868402-7#127#146#diseaseC0004364 associated_with PARP-1,autoimmune diseases
20#26#gene25976127#146#diseaseC0004364 15868402-7#20#26#gene25976 15868402-7#127#146#diseaseC0004364 associated_with PARP-1,autoimmune diseases
20#26#gene25976127#146#diseaseC0004364 15868402-7#20#26#gene25976 15868402-7#127#146#diseaseC0004364 associated_with PARP-1,autoimmune diseases
28#32#gene8505127#146#diseaseC0004364 15868402-7#28#32#gene8505 15868402-7#127#146#diseaseC0004364 associated_with PARG,autoimmune diseases
28#32#gene8505127#146#diseaseC0004364 15868402-7#28#32#gene8505 15868402-7#127#146#diseaseC0004364 associated_with PARG,autoimmune diseases

DisGeNet-2017-sample

Id Subject Object Predicate Lexical cue
T2090 478-484 gene:142 denotes PARP-1
T2091 592-608 disease:C0205851 denotes germ cell tumors
T2092 691-706 disease:C0376358 denotes prostate cancer
T2093 755-786 gene:8505 denotes poly(ADP-ribose) glycohydrolase
T2094 963-977 disease:C0596263 denotes carcinogenesis
T2095 1095-1101 gene:142 denotes PARP-1
T2096 1127-1147 disease:C0003873 denotes rheumatoid arthritis
T2097 1169-1175 gene:142 denotes PARP-1
T2098 1276-1295 disease:C0004364 denotes autoimmune diseases
R1 T2090 T2091 associated_with PARP-1,germ cell tumors
R2 T2090 T2091 associated_with PARP-1,germ cell tumors
R3 T2090 T2092 associated_with PARP-1,prostate cancer
R4 T2090 T2092 associated_with PARP-1,prostate cancer
R5 T2090 T2092 associated_with PARP-1,prostate cancer
R6 T2090 T2092 associated_with PARP-1,prostate cancer
R7 T2093 T2094 associated_with poly(ADP-ribose) glycohydrolase,carcinogenesis
R8 T2093 T2094 associated_with poly(ADP-ribose) glycohydrolase,carcinogenesis
R9 T2095 T2096 associated_with PARP-1,rheumatoid arthritis
R10 T2095 T2096 associated_with PARP-1,rheumatoid arthritis
R11 T2097 T2098 associated_with PARP-1,autoimmune diseases
R12 T2097 T2098 associated_with PARP-1,autoimmune diseases

sentences

Id Subject Object Predicate Lexical cue
TextSentencer_T1 0-68 Sentence denotes Poly(ADP-ribosyl)ation in relation to cancer and autoimmune disease.
TextSentencer_T2 69-171 Sentence denotes Carcinogenesis involves multiple steps and pathways with functional alterations in a variety of genes.
TextSentencer_T3 172-383 Sentence denotes There is accumulating evidence that a deficiency of poly(ADP-ribose) polymerase (PARP)-1 leads to DNA repair defects, genomic instability, failure of induction of cell death and modulation of gene transcription.
TextSentencer_T4 384-453 Sentence denotes PARP-1 also supports the growth of tumor cells in certain situations.
TextSentencer_T5 454-707 Sentence denotes Genetic analyses of the PARP-1 gene have demonstrated alterations in neoplasms, and a mutation affecting the conserved amino acid E251 in germ cell tumors, as well as an association of a single-nucleotide polymorphism V762A with risk of prostate cancer.
TextSentencer_T6 708-978 Sentence denotes Recent development of a selective inhibitor of poly(ADP-ribose) glycohydrolase (PARG), the enzyme primarily responsible for degradation of poly(ADP-ribose), and PARG-deficient animals should facilitate studies of the relationship of poly(ADP-ribose) with carcinogenesis.
TextSentencer_T7 979-1148 Sentence denotes Inhibitors of PARP have also suggested roles in the pathogenesis of autoimmune disease, and a promoter haplotype of PARP-1 confers a higher risk of rheumatoid arthritis.
TextSentencer_T8 1149-1296 Sentence denotes Further analysis of PARP-1, PARG and other PARP family genes should extend our understanding of the pathogenesis of cancer and autoimmune diseases.
TextSentencer_T9 1297-1482 Sentence denotes Furthermore, there is potential for sensitization to chemo- and radiation therapy of cancers as well as the treatment of autoimmune disease with development of stronger PARP inhibitors.
T1 0-68 Sentence denotes Poly(ADP-ribosyl)ation in relation to cancer and autoimmune disease.
T2 69-171 Sentence denotes Carcinogenesis involves multiple steps and pathways with functional alterations in a variety of genes.
T3 172-383 Sentence denotes There is accumulating evidence that a deficiency of poly(ADP-ribose) polymerase (PARP)-1 leads to DNA repair defects, genomic instability, failure of induction of cell death and modulation of gene transcription.
T4 384-453 Sentence denotes PARP-1 also supports the growth of tumor cells in certain situations.
T5 454-707 Sentence denotes Genetic analyses of the PARP-1 gene have demonstrated alterations in neoplasms, and a mutation affecting the conserved amino acid E251 in germ cell tumors, as well as an association of a single-nucleotide polymorphism V762A with risk of prostate cancer.
T6 708-978 Sentence denotes Recent development of a selective inhibitor of poly(ADP-ribose) glycohydrolase (PARG), the enzyme primarily responsible for degradation of poly(ADP-ribose), and PARG-deficient animals should facilitate studies of the relationship of poly(ADP-ribose) with carcinogenesis.
T7 979-1148 Sentence denotes Inhibitors of PARP have also suggested roles in the pathogenesis of autoimmune disease, and a promoter haplotype of PARP-1 confers a higher risk of rheumatoid arthritis.
T8 1149-1296 Sentence denotes Further analysis of PARP-1, PARG and other PARP family genes should extend our understanding of the pathogenesis of cancer and autoimmune diseases.
T9 1297-1482 Sentence denotes Furthermore, there is potential for sensitization to chemo- and radiation therapy of cancers as well as the treatment of autoimmune disease with development of stronger PARP inhibitors.

DisGeNET

Id Subject Object Predicate Lexical cue
T0 5-8 gene:23038 denotes ADP
T1 38-44 disease:C0006826 denotes cancer
T2 5-8 gene:23038 denotes ADP
T3 38-44 disease:C1306459 denotes cancer
T4 5-8 gene:23038 denotes ADP
T5 49-67 disease:C0004364 denotes autoimmune disease
R1 T0 T1 associated_with ADP,cancer
R2 T2 T3 associated_with ADP,cancer
R3 T4 T5 associated_with ADP,autoimmune disease